Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells
Open Access
- 1 August 2007
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 48 (8) , 1735-1745
- https://doi.org/10.1194/jlr.m700029-jlr200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Proceedings of the National Academy of Sciences, 2005
- Inactivation of NPC1L1 Causes Multiple Lipid Transport Defects and Protects against Diet-induced HypercholesterolemiaJournal of Biological Chemistry, 2005
- Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol HomeostasisJournal of Biological Chemistry, 2004
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004
- Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in ratsBritish Journal of Pharmacology, 2003
- Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic functionBritish Journal of Pharmacology, 2001
- The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeysEuropean Journal of Pharmacology, 2001
- Niemann-Pick type C: A disorder of cellular cholesterol traffickingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Evidence for a Niemann–Pick C (NPC) Gene Family: Identification and Characterization of NPC1L1Genomics, 2000
- Niemann-Pick C1 Disease Gene: Homology to Mediators of Cholesterol HomeostasisScience, 1997